Trial intelligence / Profile preview

Cardiovascular Safety of Lodenafil in CAD Patients

NCT00817830Phase 4Withdrawn

Sponsor
Cristália
Start
Nov 2008
Primary completion
May 2009
Modality
Prodrugs/Conditional Activator Small Molecules
Countries
1
01

Overview

A Phase 4 trial of lodenafil carbonate in erectile dysfunction (ED), sponsored by Cristália. Planned start Nov 2008; status: withdrawn.

02

Drugs

lodenafil carbonate
03

Conditions

erectile dysfunction (ED)

Beyond the preview

Go deeper on NCT00817830.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00817830.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call